Cervomed Inc (CRVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,123 | -5,684 | -2,559 | -11,799 | -8,047 |
| Depreciation Amortization | 78 | 54 | 27 | 98 | 71 |
| Income taxes - deferred | -1,675 | -870 | -362 | 333 | -485 |
| Accounts payable and accrued liabilities | 1,202 | 151 | -456 | 568 | 304 |
| Other Working Capital | 978 | -453 | -802 | 994 | 656 |
| Other Operating Activity | -618 | 153 | 647 | -52 | 82 |
| Operating Cash Flow | $-10,158 | $-6,648 | $-3,504 | $-9,858 | $-7,420 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18,873 | 18,866 | 393 | 16,207 | 5,732 |
| Other Financing Activity | -982 | -833 | -238 | -163 | -163 |
| Financing Cash Flow | $17,891 | $18,032 | $155 | $16,045 | $5,569 |
| Beginning Cash Position | 14,177 | 14,177 | 14,177 | 7,991 | 7,991 |
| End Cash Position | 21,910 | 25,562 | 10,828 | 14,177 | 6,140 |
| Net Cash Flow | $7,733 | $11,384 | $-3,349 | $6,186 | $-1,851 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,158 | -6,648 | -3,504 | -9,858 | -7,420 |
| Free Cash Flow | -10,158 | -6,648 | -3,504 | -9,858 | -7,420 |